Immunome Inc
NASDAQ:IMNM
Immunome Inc
NASDAQ:IMNM
Price:
22.44
USD
1.13%
Market Closed
Market Cap:
$2.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Immunome Inc
NASDAQ:IMNM
|
US |
|
N
|
NTT Data Corp
XBER:NT5
|
JP |
|
M
|
Meituan
SWB:9MD
|
CN |
|
A
|
Abbvie Inc
BMV:ABBV
|
US |
|
E
|
Empresa Distribuidora y Comercializadora Norte SA
F:PWD1
|
AR |
|
V
|
Verizon Communications Inc
XBER:BAC
|
US |
|
C
|
Canopy Growth Corp
F:11L1
|
CA |
|
V
|
Vinci SA
XMUN:SQU
|
FR |
|
P
|
Pfizer Inc
XBER:PFE
|
US |
|
Young & Co's Brewery PLC
F:YBY
|
UK |
|
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
|
IL |
|
Cigna Corp
NYSE:CI
|
US |
|
F
|
Factset Research Systems Inc
DUS:FA1
|
US |
|
Great Elm Capital Corp
NASDAQ:GECC
|
US |
|
U
|
US Foods Holding Corp
F:UFH
|
US |
|
BlackRock Inc
MIL:1BLK
|
US |
|
U
|
Universal Health Services Inc
F:UHS
|
US |
|
E
|
Erlebnis Akademie AG
F:EAD
|
DE |
Wall St Price Targets
IMNM Price Targets Summary
Immunome Inc
Immunome Inc
Wall Street analysts forecast IMNM stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for IMNM is 35.96 USD with a low forecast of 30.3 USD and a high forecast of 42 USD.
Lowest Forecast
Price Target
30.3
USD
35% Upside
Average Forecast
Price Target
35.96
USD
60% Upside
Highest Forecast
Price Target
42
USD
87% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IMNM's stock price target?
Price Target
35.96
USD
35.96
USD
According to Wall Street analysts, the average 1-year price target for IMNM is 35.96 USD with a low forecast of 30.3 USD and a high forecast of 42 USD.
What is the Revenue forecast for Immunome Inc?
Projected CAGR
95%
95%
The compound annual growth rate for Revenue over the next 8 years is 95%.
